Substandard, fake medical products increased by almost 47% from 2020 to 2021 during pandemic: report
The HinduDuring the COVID-19 pandemic, incidents of substandard and falsified medical products increased by almost 47% from 2020 to 2021. This, according to the latest report released by the Authentication Solution Providers’ Association, an organisation working against fake medical products. “Criminals saw the COVID-19 pandemic crisis as an opportunity to sell more substandard and falsified medical products, taking advantage of the vulnerability of the people in need,’’ ASPA president Nakul Pasricha said. The ASPA has studied the major counterfeit incident noticed during the COVID-19 period and its impact in the country and released a report titled – “Substandard and falsified medical products, learning from COVID-19 Pandemic and Technological tools to ensure medicines and patient safety”.
History of this topic
Coronavirus Outbreak: Indian firms under scanner for selling fake COVID-19 medicines to European countries
Firstpost
Fake and shoddy drugs a threat to people, challenge for administrators
China Daily
One in ten medicines in middle-income countries including India is fake, says WHO
India TV News
Report: Action Needed To Wipe Out Fake And Substandard Drugs
NPRDiscover Related